IRADIMED CORP (IRMD) Stock Analyst Ratings
NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to IRMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 72.42. This target is 42.62% above the current price.
IRMD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IRMD.
In the previous month the buy percentage consensus was at a similar level.
IRMD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-08-02 | Roth MKM | Maintains | Buy -> Buy |
| 2024-04-22 | Roth MKM | Reiterate | Buy |
| 2021-08-02 | Roth Capital | Maintains | Buy |